Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Immunologic responses in patients with pulmonary carcinoma receiving immunotherapy

  • 12 Accesses

  • 1 Citations

Summary

This is a preliminary report on immune responses observed in vivo and in vitro in resectable patients treated with oral BCG, and in nonresectable patients treated with autologous tumour cells complexed with PPD and with BCG applied by scarification. In some cases, to shorten the period of sensitization, transfer factor was given additionally. Several of the in vitro methods used for assessing the immune competence of the patients are shown to be sufficiently informative to warrant their use before immunotherapy in order to assess the immunologic resources of the patient. During immunotherapy, they allow monitoring the effect of the treatment.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Ariel, I. M., Avery, E. E., Kanter, L.: Primary carcinoma of the lung. Cancer 3, 229 (1950)

  2. 2.

    Ascher, M. S., Schneider, W. J., Valentine, F. T., Lawrence, H. S.: In vitro properties of leukocyte dialysates containing transfer factor. Proc. Nat. Acad. Sci. USA 71, 1178 (1974)

  3. 3.

    Axtell, L. M., Culter, S. J., Myers, M. H.: End results in cancer. Bethesda, Maryland, U.S. Department of Health, Education, and Welfare. Report no. 4, 94 (1972)

  4. 4.

    Brugarolas, A., Takita, H.: Skin tests in the staging of carcinoma of the lung. Clin. Res. 19, 737 (1971)

  5. 5.

    Brugarolas, A., Takita, H.: Immunological status in lung cancer. Chest 64, 427 (1973)

  6. 6.

    Brugarolas, A., Takita, H., Moore, C. E.: Effect of syngeneic tumour cells bound to concanavalin A on tumour growth. J. Surg. Oncol. 4, 123 (1972)

  7. 7.

    Buchberg, A., Lubliner, R., Rubin, E. H.: Carcinoma of the lung: duration of life of individuals not treated surgically. Dis. Chest 20, 257 (1951)

  8. 8.

    Cline, M. J., Swett, V. C.: The interaction of human monocytes and lymphocytes. J. Exp. Med. 128, 1309 (1968)

  9. 9.

    Garland, L. H., Sissin, M. A.: Results of radiotherapy of bronchial cancer. Radiology 76, 48 (1956)

  10. 10.

    Hallgren, H. M., Buckley, C. E., Gilbertsen, V. S., Yunis, E. J.: Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans. J. Immun. 111, 1101 (1973)

  11. 11.

    Hellstroem, I., Hellstroem, K. E., Sjoegren, H. O., Warner, G. A.: Demonstration of cell mediated immunity to human neoplasms of various histological types. Int. J. Cancer 7, 1 (1971)

  12. 12.

    Hellstroem, I., Sjoegren, H. O., Warner, G., Hellstroem, K. E.: Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasma, Int. J. Cancer 7, 226 (1971)

  13. 13.

    Higgins, G. A., Beebe, G. W.: Bronchogenic carcinoma. Factors in survival. Arch. Surg. 94, 539 (1967)

  14. 14.

    Hyde, L., Wolf, J. W., McCracken, S., Yesner, R.: Natural course of inoperable lung cancer. Chest 64, 309 (1973)

  15. 15.

    Israel, L.: Cell-mediated immunity in lung cancer patients: data, problems, and propositions. Cancer Chemotherapy Reports, Part 3, 4, 279 (1973)

  16. 16.

    Karnofsky, D.: Clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents, p. 191. New York: Columbia University Press 1949

  17. 17.

    Kurti, V., Mankiewicz, E.: In vitro study of macrophages from patients with sarcoidosis. C.M.A. Journal 107, 509 (1972)

  18. 18.

    Lawrence, H. S., Askari, S. A.: The preparation and purification of transfer factor. In: In vitro methods in cell-mediated immunity (B. R. Bloom, Ph. R. Glade, eds.) p. 531. New York-London: Academic Press 1971

  19. 19.

    Lolekha, S., Dray, S., Gotoff, S. P.: Macrophage aggregation in vitro: a correlate of delayed hypersensitivity. J. Immunol. 104, 296 (1970)

  20. 20.

    Matthews, M. J., Kanhouwa, S., Pickren, J., Robinette, D.: Frequency of residual and metastatic tumor in patients undergoing curative surgical resection fo lung cancer. Cancer Chemotherapy Reports, Part 3, 4, 63 (1973)

  21. 21.

    Mavligit, G. M., Gutterman, J. U., McBride, C. M., Hersh, E. M.: Cell-mediated immunity to human solid tumors. In vitro detection by lymphocyte blastogenic responses to cell-associated and solubilized tumor antigens. Nat. Cancer Inst. Monogr. 37, 167 (1973)

  22. 22.

    Piessens, W. F.: Evidence for human cancer immunity. A review. Cancer 26, 1212 (1970)

  23. 23.

    Rios, A., Simmons, R. L.: Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells. Int. J. Cancer 13, 71 (1974)

  24. 24.

    Seeger, R. C., Oppenheim, J. J.: Synergistic interaction of macrophages and lymphocytes in antigen-induced transformation of lymphocytes. J. Exp. Med. 132, 44 (1970)

  25. 25.

    Singer, S. J., Schick, A. F.: The properties of specific stains for electron microscopy. J. Biophys. Biochem. Cytol. 9, 519 (1961)

  26. 24.

    Takita, H., Brugarolas, A.: Adjuvant immunotherapy for bronchogenic carcinoma: preliminary results. Cancer Chemotherapy Reports, Part 3, 4 293 (1973)

  27. 27.

    Tinney, W. D.: Clinical features of bronchogenic carcinoma of the lung. Cancer 3, 229 (1950)

  28. 28.

    Vanky, F., Klein, E., Stjernswaers, J. Trempe, G.: Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patients or from healthy donors. Int. J. Cancer 16, 850 (1975)

  29. 29.

    Weiss, W.: Operative mortality and five-year survival rates in men with bronchogenic carcinoma. Chest. 66, 483 (1974)

  30. 30.

    Werdelin, O., Braendstrup, O., Pedersen, E.: Macrophage-lymphocyte clusters in the immune response to soluble protein antigen in vitro. J. Exp. Med. 140, 1245 (1974)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mankiewicz, E., Kurti, V., Munro, D.D. et al. Immunologic responses in patients with pulmonary carcinoma receiving immunotherapy. Cancer Immunol Immunother 2, 27–39 (1977). https://doi.org/10.1007/BF00199088

Download citation

Keywords

  • Carcinoma
  • Tumour Cell
  • Immune Response
  • Cancer Research
  • Preliminary Report